Dr. Michael Link, MD
Palo Alto, CA
Affiliated with a Castle Connolly Top Hospital
Who is Dr. Link, Pediatric Hematologist-Oncologist in Palo Alto, CA?
Dr. Michael Link, MD is a Pediatric Hematologist-Oncologist, who primarily practices in Palo Alto, CA. He is board certified by the American Board of Pediatrics and American Board of Dermatology. Dr. Link completed his residency at Children'S Hosp, Hematology-Internal Medicine; Children'S Hosp, Immunology; Children'S Hosp, Pediatrics. Dr. Link is fluent in English and Spanish, and is currently seeing new patients. Dr. Link’s practice accepts Kaiser Permanente, Medicare, UnitedHealthcare, Aetna, Cigna and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Link’s office at (650) 497-8000.
What are Areas of Expertise for Dr. Link?
Dr. Michael Link, MD is a highly-rated, board-certified Pediatric Hematologist-Oncologist known for expertly diagnosing, treating, and managing a wide array of related conditions or procedures. Utilizing the latest medical advancements and evidence-based practices, Dr. Link empowers patients to confidently navigate their health journey, specializing in Hodgkin's Lymphoma, Lymphoma, Non-Hodgkin's, Sarcoma, or comprehensive wellness support. Serving the Palo Alto/CA community, Dr. Link is dedicated to enhancing lives through expert, patient-centered care.
Where did Dr. Link go to medical school and complete their residency?
Fellowship: Children's Hospital Boston, Boston, MA | Dana-Farber Cancer Institute, Boston, MA | Dana-Farber Cancer Institute MA | Children's Hospital Boston MA
Residency: Children'S Hosp, Hematology-Internal Medicine; Children'S Hosp, Immunology; Children'S Hosp, Pediatrics | Children's Hospital Boston
Medical School: Stanford Univ Sch Of Med- Stanford Ca
Is Dr. Link board certified in Pediatric Hematologist-Oncologist?
Yes, Dr. Michael Link, MD is board certified by the American Board of Pediatrics , American Board of Dermatology , American Board of Dermatology since 1980, American Board of Pediatrics since 1979
What languages does Dr. Link speak?
Dr. Link and their clinical team can communicate with patients in the following languages:
English
Spanish
What conditions does Dr. Link treat?
As a Pediatric Hematologist-Oncologist, Dr. Link diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Link. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly.
Also known as:
- Hodgkin Lymphoma
- Nodular Sclerosis Hodgkin Lymphoma in Chest Lymph Nodes
- Nodular Lymphocyte Predominant Hodgkin Lymphoma in Head, Face, Neck Lymph Nodes
- Nodular Lymphocyte Predominant Hodgkin Lymphoma
- Hodgkin's Disease', 'Hodgkin's Lymphoma
- NSHL in Chest', 'Hodgkin's Lymphoma in Intrathoracic Lymph Nodes
- Hodgkin's Disease
- Lymphatic Cancer
- Reed-Sternberg Lymphoma
- NLPHL in Head and Neck', 'Hodgkin's Lymphoma in Cervical Lymph Nodes
- NLPHL', 'Lymphocyte-predominant Hodgkin's Disease
ICD-10 Codes:
- C8190: Hodgkin lymphoma, unspecified, unspecified site
- C819A: Hodgkin lymphoma, unspecified, in remission
- C8112: Nodular sclerosis Hodgkin lymphoma, intrathoracic lymph nodes
- C8170: Other Hodgkin lymphoma, unspecified site
- C8101: Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of head, face, and neck
- C8100: Nodular lymphocyte predominant Hodgkin lymphoma, unspecified site
- C8172: Other Hodgkin lymphoma, intrathoracic lymph nodes
Also known as:
- Acute Lymphoblastic Leukemia
- Acute Lymphocytic Leukemia in Remission
- Acute Myeloid Leukemia
- Acute Lymphocytic Leukemia in Relapse
- Acute Lymphocytic Leukemia
- ALL
- Acute lymphocytic leukemia
- Lymphoblastic leukemia
- ALL Leukemia in Remission
- Acute Lymphoblastic Leukemia in Remission
- Childhood Leukemia in Remission
- AML Leukemia
- Acute Myeloblastic Leukemia
- Acute Myelogenous Leukemia
- ALL Leukemia in Relapse
- Acute Lymphoblastic Leukemia in Relapse
- Recurrent Childhood Leukemia
ICD-10 Codes:
- C9100: Acute lymphoblastic leukemia not having achieved remission
- C9101: Acute lymphoblastic leukemia, in remission
- C9200: Acute myeloblastic leukemia, not having achieved remission
- C9102: Acute lymphoblastic leukemia, in relapse
Also known as:
- Cancer Chemotherapy
- Chemo treatment
- Oncology chemotherapy
- Cancer drug therapy
ICD-10 Codes:
- Z5111: Encounter for antineoplastic chemotherapy
Also known as:
- Burkitt Lymphoma
- Diffuse Large B-cell Lymphoma
- Non-Hodgkin Lymphoma
- Anaplastic Large Cell Lymphoma
- Lymphoma
- BL', 'Burkitt's Lymphoma
- High-Grade B-cell Lymphoma
- DLBCL
- Aggressive B-cell Lymphoma
- Diffuse B-cell Lymphoma
- Lymphatic Cancer
- Lymphosarcoma
- NHL
- ALCL
- T-cell lymphoma
- Large cell lymphoma
ICD-10 Codes:
- C8379: Burkitt lymphoma, extranodal and solid organ sites
- C8330: Diffuse large B-cell lymphoma, unspecified site
- C8590: Non-Hodgkin lymphoma, unspecified, unspecified site
- C8468: Anaplastic large cell lymphoma, ALK-positive, lymph nodes of multiple sites
Also known as:
- Widespread Swollen Lymph Nodes
- Localized Swollen Lymph Nodes
- Generalized lymphadenopathy
- Multiple swollen glands
- Body-wide enlarged lymph nodes
- Enlarged glands in one area
- Local lymphadenopathy
- Swollen glands
ICD-10 Codes:
- R591: Generalized enlarged lymph nodes
- R590: Localized enlarged lymph nodes
Also known as:
- Cancer Follow-up Exam
- Cancer
- Post-cancer treatment checkup
- Malignancy surveillance
- Oncology follow-up
ICD-10 Codes:
- Z08: Encounter for follow-up examination after completed treatment for malignant neoplasm
Also known as:
- Low Neutrophil Count
- Blood Disorder
- Neutropenia
- Low white blood cell count
- Neutrophil deficiency
ICD-10 Codes:
- D709: Neutropenia, unspecified
Which procedures does Dr. Link perform as a Pediatric Hematologist-Oncologist?
As a Pediatric Hematologist-Oncologist, procedures performed by a Dr. Michael Link may include:
- 3D Conformal Radiotherapy
- Adaptive Radiation Therapy (ART)
- Adrenalectomy
- Blood Thinning Therapy / Anticoagulation
- Blood Transfusion Consultation
- Blood Transfusion Follow Up
- Bone Excision
- Bone Grafting
For detailed information, please contact Dr. Link's office.
Does Dr. Link accept my insurance?
Dr. Link accepts most major insurance plans. Important: Please call our office at (650) 497-8000 before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Link accept in Palo Alto, CA?
Dr. Link in Palo Alto, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
All Other Third Party
Blue Shield of California
California Water Service Group
Central California Alliance for Health
CVS Health (formerly Aetna)
Express Scripts
Health Plan of San Mateo
Kaiser Permanente
UnitedHealthcare
Valley Health Plan
View All Insurances
Where is Dr. Link's office located?
Recognitions
Awards
Annual Memorial Lectureship, Pediatric Cancer Research Foundation
Washington University School of Medicine
Ben Abelson Memorial Visiting Professor
Alpha Omega Alpha, Alpha Omega Alpha
21st Annual W.W. Sutow Visiting Lecturer in Pediatric Oncology, MD An
Brent Eley Visiting Professor in Pediatric Oncology,
University of Colorado Cancer Center and the Childrens Hospital, Denve
Phi Beta Kappa
The Royal Academy of Paediatrics and Child Health (June)
Honorary Fellow
Publications
Adolescent and Young Adult Oncology, Version 2.2014
JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORK, 2014
Relapse after treatment of pediatric hodgkin lymphoma
PEDIATRIC BLOOD & CANCER, 2013
The Impact of Drug Shortages on Children with Cancer - The Example of Mechlorethamine
NEW ENGLAND JOURL OF MEDICINE, 2012
Extremely low-frequency magnetic fields and survival from childhood acute lymphoblastic leukemia
BLOOD CANCER JOURL, 2012
Adolescent and young adult oncology. Clinical practice guidelines in oncology.
Jourl of the tiol Comprehensive Cancer Network, 2012
ALK+ aplastic large cell lymphoma exhibits phosphatidylinositol-3 kise
PEDIATRIC BLOOD & CANCER, 2012
Association Between Radiotherapy vs No Radiotherapy Based on Early Response to VAMP Chemotherapy
JAMA-JOURL OF THE AMERICAN MEDICAL ASSOCIATION, 2012
Chemotherapy Drug Shortages in the United States: Genesis and Potential Solutions
JOURL OF CLINICAL ONCOLOGY, 2012
Complete Ocular Paresis in a Child with Posterior Fossa Syndrome
PEDIATRIC NEUROSURGERY, 2012
Second Malignt Neoplasms in Survivors of Pediatric Hodgkin's Lymphoma Treated With Low
JOURL OF CLINICAL ONCOLOGY, 2010
The Impact of the Privacy Rule on Cancer Research
JOURL OF CLINICAL ONCOLOGY, 2009
Non-aplastic peripheral T-cell lymphoma in childhood and adolescence
PEDIATRIC BLOOD & CANCER, 2008
Nodular lymphocyte-predomint Hodgkin lymphoma presenting as fulmint hepatic failure in a pediatric
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2008
Osteosarcoma: The addition of muramyl tripeptide to chemotherapy improves overall survival
JOURL OF CLINICAL ONCOLOGY, 2008
Treatment of metastatuc Ewing Sarcoma
PEDIATRIC BLOOD & CANCER, 2007
Fil results of a prospective clinical trial with VAMP
JOURL OF CLINICAL ONCOLOGY, 2007
Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive
BLOOD, 2007
Magnetic field exposure and prognostic factors in childhood leukemia
BIOELECTROMAGNETICS, 2007
Magnetic field exposure and long-term survival among children with leukaemia
BRITISH JOURL OF CANCER, 2006
Intensive therapy with growth factor support for patients with Ewing tumor metastatic at diagnosis
JOURL OF CLINICAL ONCOLOGY, 2006
Review of tonsillar lymphoma in pediatric patients from the Pediatric Oncology Group
PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 2005
Osteosarcoma: A randomized, prospective trial of the addition of ifosfamide and
JOURL OF CLINICAL ONCOLOGY, 2005
Epstein-Barr virus-associated peripheral T-cell lymphoma
PEDIATRIC BLOOD & CANCER, 2005
High-dose therapy and autologous hematopoietic stem
JOURL OF CLINICAL ONCOLOGY, 2004
Risk-adapted, combined-modality therapy with VAMP
JOURL OF CLINICAL ONCOLOGY, 2004
Cyclophosphamide dose intensification during induction therapy for intermediate
CLINICAL CANCER RESEARCH, 2004
Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone
JOURL OF CLINICAL ONCOLOGY, 2004
High-dose methotrexate pharmacokinetics and outcome of children and young adults with osteosarcoma
CANCER, 2004
tiol Institutes of Health State-of-the-Science Conference Statement: Symptom Magement in Cancer
Patrick, D. L., Ferketich, S. L., Frame, P. S., Harris, J. J., Hendric
Prognostic factors for children with Hodgkin's disease treated with combined-modality therapy
JOURL OF CLINICAL ONCOLOGY, 2003
Presurgical chemotherapy compared with immediate surgery
JOURL OF CLINICAL ONCOLOGY, 2003
Addition of ifosfamide and etoposide to standard chemotherapy
NEW ENGLAND JOURL OF MEDICINE, 2003
Prognostic factors and clinical outcomes
JOURL OF CLINICAL ONCOLOGY, 2003
Children from ethnic minorities have benefited equally
JOURL OF CLINICAL ONCOLOGY, 2002
tiol action plan for childhood cancer: report of the tiol summit meetings on childhood cancer.
CA: a cancer jourl for clinicians, 2002
Assessment of lymphadenopathy in children
PEDIATRIC CLINICS OF NORTH AMERICA, 2002
Minimax two-stage-designs with applications to tissue banking case-control studies
STATISTICS IN MEDICINE, 2002
Treatment of unfavorable childhood Hodgkin's disease with VEPA and low-dose
JOURL OF CLINICAL ONCOLOGY, 2002
VAMP and low-dose, involved-field radiation for children and adolescents with favorable
JOURL OF CLINICAL ONCOLOGY, 2002
Bone marrow stroma-supported culture of T
LEUKEMIA, 2002
Dose escalation and pharmacokinetics of pegylated liposomal doxorubicin
CLINICAL CANCER RESEARCH, 2002
Phase II/III trial of etoposide and high-dose ifosfamide
JOURL OF CLINICAL ONCOLOGY, 2002
Efficacy of ifosfamide
MEDICAL AND PEDIATRIC ONCOLOGY, 2001
Which patients with microscopic disease
JOURL OF CLINICAL ONCOLOGY, 2001
Controversies in the magement of paratesticular rhabdomyosarcoma
Semirs in pediatric surgery, 2001
Presurgical window of carboplatin and surgery and multidrug chemotherapy
JOURL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2001
What constitutes optimal therapy for patients with rhabdomyosarcoma of the female genital tract?
Arndt, C. A., Doldson, S. S., Anderson, J. R., Andrassy, R. J., Laurie, 2001
Thyroid carcinoma after successful treatment of osteosarcoma: A report of three patients
JOURL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2001
Attitudes and practices among pediatric oncologists regarding end-of-life care
JOURL OF CLINICAL ONCOLOGY, 2001
New recurring cytogenetic abnormalities
BLOOD, 2000
Benefit of intensified therapy for patients with local or regiol embryol rhabdomyosarcoma
JOURL OF CLINICAL ONCOLOGY, 2000
Effects of cranial radiation in children with high risk T cell acute lymphoblastic leukemia
LEUKEMIA, 2000
Burkitt lymphoma is immunophenotypically different from Burkitt-like lymphoma in young persons
Hutchison, R. E., Finch, C., Kepner, J., Fuller, C., Bowman, P., Link,, 2000
Significance of commonly used prognostic factors differs
LEUKEMIA, 1999
Intensive high-dose asparagise consolidation improves survival for pediatric patients with T cell
LEUKEMIA, 1999
Treatment of localized primary non-Hodgkin's lymphoma of bone in children
JOURL OF CLINICAL ONCOLOGY, 1999
Childhood acute lymphoblastic leukemia with the MLL-ENL fusion
JOURL OF CLINICAL ONCOLOGY, 1999
Acute lymphoblastic leukemia with the (8;14)(q24;q32) translocation
LEUKEMIA, 1999
Treatment of metastatic osteosarcoma at diagnosis: A pediatric oncology group study
JOURL OF CLINICAL ONCOLOGY, 1998
A multidiscipliry study investigating radiotherapy in Ewing's sarcoma: End results of POG #8346
INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998
Randomized trial of r
JOURL OF CLINICAL ONCOLOGY, 1998
E2A-PBX1 chimeric transcript status at end of consolidation is not predictive of treatment outcome
BLOOD, 1998
Fractioted cyclophosphamide and back to back high dose methotrexate and cytosine arabinoside
MEDICAL AND PEDIATRIC ONCOLOGY, 1997
Treatment of children and young adults with early-stage non-Hodgkin's lymphoma
NEW ENGLAND JOURL OF MEDICINE, 1997
Lack of ETV6 (TEL) gene rearrangements or p16(INK4A)
LEUKEMIA, 1997
Altered expression of p53
JOURL OF CLINICAL ONCOLOGY, 1997
A feasibility, toxicity, and early response study of etoposide, ifosfamide, and vincristine for the
JOURL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1997
Frequent and selective methylation of p15 and deletion of both p15 and p16 in T
CANCER RESEARCH, 1997
Case-control study suggests a favorable impact of TEL rearrangement in patients with B
BLOOD, 1997
Use of an anti-ALK antibody in the characterization of aplastic large-cell lymphoma of childhood
ANLS OF ONCOLOGY, 1997
NCCN pediatric osteosarcoma practice guidelines. The tiol Comprehensive Cancer Network.
Oncology (Williston Park, N.Y.), 1996
Improved survival for children with B-cell acute lymphoblastic leukemia
JOURL OF CLINICAL ONCOLOGY, 1996
High incidence of potential p53 ictivation
BLOOD, 1996
Uniform approach to risk classification
JOURL OF CLINICAL ONCOLOGY, 1996
STAGE-SPECIFIC AND LINEAGE
EXPERIMENTAL HEMATOLOGY, 1995
B-CELL LINEAGE CONFERS A FAVORABLE OUTCOME AMONG CHILDREN AND ADOLESCENTS WITH LARGE
JOURL OF CLINICAL ONCOLOGY, 1995
SAFETY AND EFFICACY OF L-LEUCOVORIN RESCUE FOLLOWING HIGH-DOSE METHOTREXATE FOR OSTEOSARCOMA
MEDICAL AND PEDIATRIC ONCOLOGY, 1995
TREATMENT OF OSTEOSARCOMA WITH IFOSFAMIDE - COMPARISON OF RESPONSE IN PEDIATRIC
MEDICAL AND PEDIATRIC ONCOLOGY, 1995
ABVD/MOPP AND LOW-DOSE INVOLVED-FIELD RADIOTHERAPY
JOURL OF CLINICAL ONCOLOGY, 1994
HYPNOSIS IN THE PREVENTION OF CHEMOTHERAPY-RELATED USEA AND VOMITING IN CHILDREN
JOURL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS, 1994
FREQUENCY AND PROGNOSTIC-SIGNIFICANCE OF HRX REARRANGEMENTS IN INFANT ACUTE LYMPHOBLASTIC
BLOOD, 1994
SIMULTANEOUS EXPRESSION OF RBTN-2 AND BCR
LEUKEMIA, 1994
PRESENTING CHARACTERISTICS OF TRISOMY
CANCER GENETICS AND CYTOGENETICS, 1994
MIC2 ALYSIS IN PEDIATRIC LYMPHOMAS AND LEUKEMIAS
HUMAN PATHOLOGY, 1994
EWINGS-SARCOMA - ROUTINE DIAGNOSTIC UTILIZATION OF MIC2 ALYSIS - A PEDIATRIC-ONCOLOGY-GROUP
HUMAN PATHOLOGY, 1994
SECONDARY BREAST-CANCER IN PATIENTS PRESENTING WITH OSTEOSARCOMA
MEDICAL AND PEDIATRIC ONCOLOGY, 1994
HODGKINS-DISEASE IN THE VERY YOUNG
Cleary, S. F., Link, M. P., Doldson, S. S., 1994
IMMUNOCYTOCHEMICAL STUDY OF 12E7 IN SMALL ROUND-CELL TUMORS OF CHILDHOOD
HISTOPATHOLOGY, 1993
DETECTION OF THE (11 22)(Q24 Q12) TRANSLOCATION OF EWINGS
AMERICAN JOURL OF PATHOLOGY, 1993
HRX INVOLVEMENT IN DENOVO AND SECONDARY LEUKEMIAS WITH DIVERSE CHROMOSOME 11Q23 ABNORMALITIES
BLOOD, 1993
ACUTE HYPERSENSITIVITY REACTIONS TO ETOPOSIDE IN A VEPA REGIMEN FOR HODGKINS-DISEASE
JOURL OF CLINICAL ONCOLOGY, 1993
LABORATORY CLINICAL INTERFACE
Link, M. P., Stevens, J., Friend, S. H., Israel, M. A., Knudson, A. G., 1993
CLINICAL-FEATURES AND OUTCOME OF T
BLOOD, 1993
A SERINE PROLINE-RICH PROTEIN IS FUSED TO HRX IN T(4-11) ACUTE LEUKEMIAS
BLOOD, 1993
The multi-institutiol osteosarcoma study: an update.
Cancer treatment and research, 1993
LANGERHANS CELL HISTIOCYTOSIS PRESENTING WITH THE SUPERIOR VE-CAVA SYNDROME - A CASE-REPORT
MEDICAL AND PEDIATRIC ONCOLOGY, 1993
Osteosarcoma in adolescents and young adults
Cancer treatment and research, 1993
A STUDY OF TOXICITY AND COMPARATIVE THERAPEUTIC EFFICACY OF VINDESINE-PREDNISONE VS VINCRISTINE
INVESTIGATIOL NEW DRUGS, 1992
CHILDHOOD MALIGNT NON-HODGKIN LYMPHOMAS OF UNCOMMON HISTOLOGY
LEUKEMIA, 1992
MORPHOLOGICAL, IMMUNOLOGICAL AND CYTOGENETIC STUDIES IN CHILDREN WITH ACUTE LYMPHOBLASTIC
LEUKEMIA
What is Dr. Link's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Link's National Provider Identifier (NPI) number is 1982742862.
What common questions do patients ask about Dr. Link?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Link
What is Dr. Michael Link's specialty?
Dr. Link is a Pediatric Hematologist-Oncologist near Palo Alto, CA. A pediatrician trained in the integration of pediatrics, hematology, and oncology, specializing in the recognition and management of blood disorders and cancer in children. This expert provides comprehensive care for conditions such as anemia, bleeding disorders, and various pediatric cancers. Contact Dr. Link to book an appointment today.
Is this Dr. Michael Link affiliated with a ranked Castle Connolly Top Hospital?
Yes, Dr. Link is affiliated with Stanford Health Care - Stanford Hospital which is a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are healthcare institutions recognized for their excellence in specific medical procedures and overall patient care. They are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals
Where can I learn more about Pediatric Hematologist-Oncologist?
Explore Pediatric Hematologist-Oncologist with insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.
Is Michael Link accepting new patients in Palo Alto, CA?
Yes, Dr. Michael Link is accepting new patients at this time.
Does Dr. Michael Link offer online booking?
Please contact Dr. Link's office at (650) 497-8000 for information about online booking, telehealth, or to schedule an appointment.
How can I make an appointment with Michael Link?
Please contact Dr. Link's office at (650) 497-8000 for information regarding telehealth appointment availability or for scheduling assistance.
Which board certifications does Dr. Michael Link have?
Dr. Michael Link is certified by the American Board of Pediatrics and American Board of Dermatology.
Other Pediatric Hematologist-Oncologist Near Palo Alto, CA
Pediatric Hematologist-Oncologist
Accepting patientsPediatric Hematologist-Oncologist
Accepting patientsPediatric Hematologist-Oncologist
Accepting patients